Quiero saber acerca de...

jbell on DSKJLSW7X2PROD with NOTICES

Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Alexander Yakovlev, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5206, MSC 7846, Bethesda, MD 208927846, 301
4351254, yakovleva@csr.nih.gov.
Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Genetics of Health and Disease Study Section.
Date: March 12, 2021.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Christopher Payne, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Rm. 2208, Bethesda, MD 20892, 3014023702, christopher.payne@nih.gov.
Name of Committee: Oncology 2
Translational Clinical Integrated Review Group; Cancer Immunopathology and Immunotherapy Study Section.
Date: March 12, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Zhang-Zhi Hu, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6186, MSC 7804, Bethesda, MD 20892, 301 594
2414, huzhuang@csr.nih.gov.
Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group;
Health Services: Quality and Effectiveness Study Section.
Date: March 12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Shalanda A. Bynum, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3206, Bethesda, MD 20892, 3017554355, bynumsa@csr.nih.gov.
Name of Committee: Biology of Development and Aging Integrated Review Group; Drug Discovery and Molecular Pharmacology Study Section.
Date: March 12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Jeffrey Smiley, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of
VerDate Sep<11>2014

17:13 Feb 03, 2021

Jkt 253001

Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301594
7945, smileyja@csr.nih.gov.
Name of Committee: Oncology 1Basic Translational Integrated Review Group;
Cancer Etiology Study Section.
Date: March 1, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Sarita Kandula Sastry, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD
20782, 3014024788, sarita.sastry@nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333, 93.337, 93.39393.396, 93.83793.844, 93.84693.878, 93.892, 93.893, National Institutes of Health, HHS
Dated: January 26, 2021.
Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy.

8215

Bethesda, MD 208929750, 2402766348, lymanc@mail.nih.gov.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
Information is also available on the Institutes/Centers home page: http
deainfo.nci.nih.gov/advisory/fac/fac.htm, where an agenda, instructions for access, and any additional information for the meeting will be posted when available.
Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS

FR Doc. 202102291 Filed 2321; 8:45 am
Dated: January 29, 2021.
Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy.

BILLING CODE 414001P

FR Doc. 202102313 Filed 2321; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10a of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Frederick National Laboratory Advisory Committee to the National Cancer Institute.
The meeting will be held virtually and is open to the public. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH
Videocasting and Podcasting website http videocast.nih.gov/.
Name of Committee: Frederick National Laboratory Advisory Committee to the National Cancer Institute.
Date: February 23, 2021.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Ongoing and new activities at the Frederick National Laboratory for Cancer Research.
Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 Virtual Meeting.
Contact Person: Caron A. Lyman, Ph.D., Executive Secretary, National Cancer Institute, National Institutes of Health, 9609
Medical Center Drive, Room 7W126,
PO 00000

Frm 00056

Fmt 4703

Sfmt 4703

National Institute on Aging; Notice of Closed Meetings Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis Panel; GEMSSTAR.
Date: March 1, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 Video Meeting.
Contact Person: Isis S. Mikhail, MD, MPH, DrPH, Scientific Review Officer, Scientific Review Branch, National Institute on Aging, National Institutes of Health, Gateway Building 2C212, 7201 Wisconsin Avenue,
E:FRFM04FEN1.SGM

04FEN1